Keith DiPetrillo in

Keith DiPetrillo

Login to view DISC.
Scientific Director, NonClinical Safety at Bristol Myers Squibb
📍 Phillipsburg, New Jersey, United States

Keith DiPetrillo is a Scientific Director at Bristol Myers Squibb, specializing in nonclinical safety and toxicology. An innovative and creative pharmacologist with a PhD from Dartmouth, he has a strong record of leading teams to advance drug compounds into clinical trials, particularly in oncology and cardiovascular diseases. People often describe him as skilled, knowledgeable, and pragmatic.

Outside of his scientific work, Keith is committed to supporting health-related causes. He actively participates in and raises funds for the American Heart Associations Heart Walk, demonstrating a personal investment in advancing cardiovascular research and community well-being.

He is the editor of a book titled "Cardiovascular Genomics: Methods and Protocols, " part of the Methods in Molecular Biology series.

Read the full overview →
Experience
27 Years
Current Role
Scientific Director, NonClinical Safety
Job Level
Mid-senior
Location
Phillipsburg, New Jersey, United States
Personality Overview

How Keith shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Keith cares about

Drug Discovery
His career is focused on identifying and advancing lead compounds (small molecules and biologics) into clinical trials across multiple therapeutic areas.
Nonclinical Safety
His current role is Scientific Director of NonClinical Safety, serving as the project toxicologist for multiple drug development programs in oncology and neuroscience.
+5 more topics Login to view topics
Career

Work history

11-2024
Scientific Director, NonClinical Safety
Bristol Myers Squibb
8-2020 - 11-2024
Scientific Director, Discovery Toxicology
Bristol Myers Squibb
3-2018 - 8-2020
Director, Translational Safety In Vivo Models
Novartis Institutes for BioMedical Research (NIBR)
1-2016 - 2-2018
Director, Discovery Pharmacology
Insmed Incorporated
5-2005 - 12-2015
Senior Investigator I
Novartis Institutes for BioMedical Research (NIBR)
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1998 - 2002
PhD
Geisel School of Medicine at Dartmouth
1993 - 1998
BS
University of Rhode Island
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Bristol Myers Squibb Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Keith. Free, 10 seconds.